Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP730180.RAbSjGur48ksqm9d-RZ0N2heQxlP-9NWAAiK3u5cq5x2U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP730180.RAbSjGur48ksqm9d-RZ0N2heQxlP-9NWAAiK3u5cq5x2U130_assertion type Assertion NP730180.RAbSjGur48ksqm9d-RZ0N2heQxlP-9NWAAiK3u5cq5x2U130_head.
- NP730180.RAbSjGur48ksqm9d-RZ0N2heQxlP-9NWAAiK3u5cq5x2U130_assertion description "[We found that patients expressing high levels of miR-21 had significantly inferior recurrence-free cancer-specific survival (RF-CSS): HR=1.26; 95% CI: 1.15-1.60; P<0.001.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP730180.RAbSjGur48ksqm9d-RZ0N2heQxlP-9NWAAiK3u5cq5x2U130_provenance.
- NP730180.RAbSjGur48ksqm9d-RZ0N2heQxlP-9NWAAiK3u5cq5x2U130_assertion evidence source_evidence_literature NP730180.RAbSjGur48ksqm9d-RZ0N2heQxlP-9NWAAiK3u5cq5x2U130_provenance.
- NP730180.RAbSjGur48ksqm9d-RZ0N2heQxlP-9NWAAiK3u5cq5x2U130_assertion SIO_000772 23011541 NP730180.RAbSjGur48ksqm9d-RZ0N2heQxlP-9NWAAiK3u5cq5x2U130_provenance.
- NP730180.RAbSjGur48ksqm9d-RZ0N2heQxlP-9NWAAiK3u5cq5x2U130_assertion wasDerivedFrom befree-20140225 NP730180.RAbSjGur48ksqm9d-RZ0N2heQxlP-9NWAAiK3u5cq5x2U130_provenance.
- NP730180.RAbSjGur48ksqm9d-RZ0N2heQxlP-9NWAAiK3u5cq5x2U130_assertion wasGeneratedBy ECO_0000203 NP730180.RAbSjGur48ksqm9d-RZ0N2heQxlP-9NWAAiK3u5cq5x2U130_provenance.